Absorbable skull forming device

By using skull molding devices with magnesium zinc calcium alloy and polylactic acid layer, the problems of poor corrosion and biocompatibility of traditional devices are solved, safe and effective skull molding is achieved, surgical risks and complications are reduced, and personalized treatment is provided plan.

CN119055338APending Publication Date: 2024-12-03PLASTIC SURGERY HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411318374.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-20
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Traditional spring skull molding devices are prone to corrosion and have poor biocompatibility. They require secondary surgery to remove, which increases the risk of surgery and the incidence of complications.

Method used

Using alloy materials of magnesium, zinc and calcium, the polylactic acid layer is coated on the outside, designed to include elastic parts, connection parts and joint parts, and the joint part is equipped with multiple U-shaped joint teeth, providing the device with good biocompatibility and Absorptive, can gradually degrade in the body, avoiding secondary surgery.

Benefits of technology

Improves biocompatibility and safety, reduces postoperative complications and secondary surgery risks, provides safer and more effective skull shaping surgery, avoiding surgical trauma and potential infection risks.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055338A_ABST
    Figure CN119055338A_ABST
Patent Text Reader

Abstract

The invention discloses an absorbable skull forming device which comprises a body, and the body is an alloy comprising the following components: magnesium, zinc and calcium. The alloy containing magnesium, zinc and calcium is selected, the mechanical strength is enhanced, the degradation rate is controlled, and the alloy has certain elasticity and can meet the requirements of spring-assisted skull plasty; the alloy can be absorbed, the absorption time is 2-5 years, the biocompatibility and safety are improved, and postoperative complications and secondary surgical risks are reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medical devices, and in particular to an absorbable skull shaping device. Background Art

[0002] Craniosynostosis is a congenital skull deformity in which the sutures of the skull (cranial sutures) close prematurely during infancy, resulting in the restriction of normal skull growth and the inability of the skull to expand normally, which in turn causes problems such as skull developmental deformity, increased intracranial pressure, and intellectual disability. Spring-assisted cranioplasty is an effective method for treating craniosynostosis and other craniofacial deformities. It applies continuous mechanical force to the immature skull sutures, such as Figure 4 , by gradually expanding the skull, skull remodeling and normal brain development are achieved. When spring-assisted cranioplasty is used to treat craniosynostosis, when the stressed cranial suture reaches optimal expansion, the suture line is reconstructed, bone fibers are rearranged, cartilage is formed, absorbed and ossified. This process will continue until the skull structural environment reaches a stable state. Compared with cranial vault reconstruction surgery, spring-assisted cranioplasty has the advantages of less scarring, shorter hospitalization time and lower blood transfusion rate.

[0003] However, traditional spring skull molding devices are prone to corrosion and have poor biocompatibility, requiring a second surgery to remove the spring, greatly increasing the surgical risk and incidence of complications. Summary of the invention

[0004] In view of the above technical problems existing in the prior art, the present invention provides an absorbable skull shaping device with good biocompatibility and absorbability.

[0005] The invention discloses an absorbable skull shaping device, comprising a body, wherein the body is an alloy comprising the following components: magnesium, zinc and calcium.

[0006] Preferably, the outer side of the body is coated with a polylactic acid coating of 0.1-1 mm.

[0007] Preferably, the weight of the alloy components is: 92 g magnesium, 5 g zinc and 3 g calcium, and the thickness of the polylactic acid coating is 0.5 mm.

[0008] Preferably, the body comprises an elastic portion, a connecting portion and a joining portion.

[0009] The connecting portion is arranged at both sides of the elastic portion, and the engaging portion is arranged at the outer end of the connecting portion.

[0010] Preferably, the engaging portion comprises engaging teeth.

[0011] Preferably, the engaging teeth include a plurality of U-shaped engaging teeth spaced apart at the outer end of the connecting portion;

[0012] The U-shaped engaging teeth face outward.

[0013] Preferably, the root of the U-shaped engaging tooth is fixed on the connecting portion, and the end of the U-shaped engaging tooth is hook-shaped.

[0014] Preferably, the interval between the two ends of the body is in the range of 10-60 mm, and the length of the connecting portion is 30-40 mm;

[0015] In the extended state: the angle of the connection is 100-130 degrees.

[0016] Preferably, the length of the joint is 10-12 mm;

[0017] The root distance between the two U-shaped engaging teeth is 3-4 mm;

[0018] The length of the root is 3-4 mm; the length of the tip is 2-3 mm;

[0019] The yield strength of the body is: 150Mpa; shear modulus G: 16.67Gpa; elastic modulus E: 45GPa; looseness ratio ν\nuν: 0.35; wire diameter d: 1.5mm; torsion angle: 10.6 degrees; maximum elastic force: 8-10N; torque: 0.28N·m; stiffness: k=160N / m.

[0020] Preferably, the body is installed in a suture of the skull, and the joint portion cooperates with the skull on both sides of the suture.

[0021] Compared with the prior art, the beneficial effects of the present invention are: an alloy containing magnesium, zinc and calcium is selected to enhance the mechanical strength and control the degradation rate; the alloy has a certain elasticity to meet the requirements of spring-assisted cranioplasty; the alloy can be absorbed, and the absorption time is 2-5 years, which improves biocompatibility and safety, and reduces postoperative complications and the risk of secondary surgery. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 It is a schematic structural diagram of the absorbable skull shaping device of the present invention;

[0023] Figure 2 is a schematic diagram of the compression of the absorbable cranioplasty device;

[0024] Figure 3 is a schematic diagram of the structure of the engaging teeth;

[0025] Figure 4 is a schematic diagram of spring-assisted cranioplasty.

[0026] Markings in the figure: 1 main body, 2 connecting part, 3 elastic part, 4 joint part, 41 joint tooth, 42 U-shaped joint tooth, 43 root, 45 end, 5 skull, 51 suture. DETAILED DESCRIPTION

[0027] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0028] The present invention is further described in detail below in conjunction with the accompanying drawings:

[0029] An absorbable cranioplasty device, such as Figure 1-3 As shown, it comprises a body 1, and the body 1 is an alloy comprising the following components: magnesium, zinc and calcium.

[0030] Specifically, the weight ratio of magnesium, zinc and calcium is: 80-95g: 3-8g: 1-5g. The outer side of the body 1 is coated with a 0.1-1 mm polylactic acid coating.

[0031] More specifically, the weight of each component per 100 g of the alloy is: 92 g of magnesium, 5 g of zinc, and 3 g of calcium, and the thickness of the polylactic acid coating is 0.5 mm.

[0032] An alloy containing magnesium, zinc and calcium is selected to enhance the mechanical strength and control the degradation rate. The alloy has a certain elasticity to meet the requirements of spring-assisted cranioplasty. The alloy can be absorbed within 2-5 years, which improves biocompatibility and safety and reduces postoperative complications and the risk of secondary surgery.

[0033] Magnesium (Mg): 92%, as a matrix metal, has strong biocompatibility, can be fully absorbed by the human body and promote tissue healing. Zinc (Zn): 5%, increases the mechanical strength of the spring and slows down the degradation rate. Calcium (Ca): 3%, enhances bioactivity and biocompatibility, helps control the degradation rate and promotes bone healing. The introduction of calcium helps to improve the toughness and fatigue resistance of the alloy, ensuring that the spring will not fail prematurely due to stress concentration during long-term use.

[0034] Adding zinc and calcium to magnesium alloys can improve the corrosion resistance of magnesium by forming Zn-Ca phase compounds, thereby extending the degradation time. This is very important for the design goal of not completely degrading within one year but completely degrading within three years.

[0035] The surface of the spring is coated with a 0.5 mm thick polylactic acid (PLA) coating. The degradation rate of PLA in the body is approximately 0.1 to 0.5 mm per year. This rate varies depending on the molecular weight, crystallinity and environmental conditions of the PLA. Choose high molecular weight, high crystallinity PLA. High molecular weight and high crystallinity PLA can ensure that the spring will not degrade within 1 year after the implantation surgery, reduce corrosion and hydrogen production, and ensure the continuous expansion effect of the spring on the skull. After 1 year, the spring begins to gradually degrade in the body and is eventually completely absorbed within 2-3 years, avoiding the risk of secondary surgery to remove the spring, and also avoiding the potential infection risk and foreign body sensation caused by the long-term burial of the spring in the body.

[0036] At present, the treatment cycle of spring-assisted cranioplasty for craniosynostosis is usually 3 to 12 months. To ensure the treatment effect, the coating thickness needs to exceed the degradation thickness of 1 year. Therefore, a 0.5 mm thick PLA coating is selected to ensure that it will not degrade prematurely and will not stay in the body for too long after the treatment period. It is expected that the spring can be completely degraded within 2-3 years.

[0037] In terms of structural design, the body 1 includes an elastic portion 3, a connecting portion 2 and a joint portion 4. The connecting portion 2 is arranged on both sides of the elastic portion 3, and the joint portion 4 is arranged at the outer end of the connecting portion 2. The elastic portion is a V-shaped or U-shaped twistable structure.

[0038] like Figure 3 , the engaging portion 4 includes engaging teeth 41. The engaging teeth 41 include a plurality of U-shaped engaging teeth 42 spaced apart at the outer end of the connecting portion 2, forming a three-tooth structure; the U-shaped engaging teeth 42 face outward. The root 43 of the U-shaped engaging tooth 42 is fixed on the connecting portion 2, and the end 45 of the U-shaped engaging tooth 42 is hook-shaped. Compared with the existing single-tooth structure, this structure has stronger stability and is not easy to shift. The increase in contact area makes the force on the edge of the suture more uniform, avoiding bone force damage and defects caused by the small contact point area between the spring and the edge of the suture.

[0039] The interval between the two ends of the body is in the range of 10-60 mm. Figure 1 60mm in extended state. Figure 2 In the compressed state, the length of the connecting part is 10mm, and the length of the connecting part is 30-40mm. In the extended state, the angle of the connecting part is 100-130 degrees, preferably 120 degrees. The length of the joint 4 is 10-12mm, preferably 35mm; the root spacing of two adjacent U-shaped joint teeth 42 is 3-4mm, preferably 3mm; the length of the root is 3-4mm, preferably 3mm; the length of the end is 2-3mm, preferably 2mm.

[0040] In a more specific structure, the yield strength of the body is: 150 MPa; shear modulus G: 16.67 Gpa; elastic modulus E: 45 GPa; looseness ratio ν\nuν: about 0.35; wire diameter d: 1.5 mm; torsion angle (θ): 10.6 degrees; maximum elastic force: 8-10 N; torque (T): 0.28 N·m; stiffness: k=160 N / m.

[0041] The body 1 is installed in the suture 51 of the skull 5, and the joint 4 cooperates with the skull 5 on both sides of the suture 51. The device utilizes the biodegradable property of magnesium alloy, and can be absorbed after minimally invasive implantation, and elastically expands the skull suture to promote suture osteogenesis and achieve skull shaping.

[0042] The present invention utilizes the unique properties of magnesium alloy to provide a spring device with good biocompatibility, strong controllability and low corrosion, which can achieve gradual expansion and remodeling of the skull through minimally invasive surgery. The absorbable performance of the spring avoids the risk of secondary surgery and reduces the burden on patients.

[0043] Specifically, improve biocompatibility: use magnesium alloy materials as springs to reduce stimulation and side effects to tissues, and gradually degrade after surgery, without the need for secondary surgery to remove them. Reduce surgical trauma: design a minimally invasive implant spring system to reduce surgical difficulty and patient recovery time. Enhance spring stability and avoid the risk of spring displacement. Enhance treatment effect: through the continuous expansion force of the spring, the skull can be gradually expanded to promote the normal development of the skull, which is suitable for the treatment of craniosynostosis and other diseases. Achieve personalized treatment: provide a spring design that can be adjusted according to the patient's specific situation to meet the treatment needs of different patients.

[0044] The present invention provides a simple, controllable and economical solution while safely and effectively treating abnormal skull development diseases. Due to the absorbability of the spring material, there is no need for a second surgery to remove the spring after surgery, which reduces the surgical risk and pain of the patient and improves the convenience and comfort of postoperative recovery. It also avoids the potential infection risk and foreign body sensation caused by the long-term burial of the spring in the body. It can reduce surgical trauma, shorten the recovery period, improve biocompatibility, avoid removal after a second surgery, reduce the incidence of complications, and reduce the burden on patients. Through clever design and material selection, a safe, efficient and controllable skull shaping device is realized.

[0045] The present invention can promote the natural growth and healing of the skull: by elastically expanding the skull sutures, the device can continuously apply appropriate force to the sutures to promote the osteogenesis of the suture edges. The contact points of the three-tooth structure design make the force more uniform, effectively avoiding the bone damage and defects that may be caused by the traditional single-tooth structure.

[0046] The present invention is conducive to personalized treatment, and can be customized according to the specific conditions of the patient, and the mechanical parameters and degradation rate of the spring can be adjusted to meet the needs of different patients and provide personalized treatment plans. The expansion effect of the spring and the degradation of the magnesium alloy are monitored by micro-CT scanning and biochemical analysis to ensure the safety and effectiveness of the device. The high molecular weight and high crystallinity PLA coating design ensures the stability of the spring in the body and reduces the incidence of postoperative complications, such as displacement of the implant, re-closure of the bone suture caused by premature degradation, and other problems. Through material improvement and morphological design, the present invention can maintain long-term effectiveness after implantation, gradually promote the natural growth and healing of the skull, and ultimately achieve a good skull molding effect.

[0047] The magnesium alloy-based spring-assisted skull shaping device of the present invention provides an innovative solution, which significantly improves the safety, effectiveness and controllability of skull shaping surgery through reasonable material and structural design, and has broad application prospects.

[0048] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. An absorbable skull shaping device, characterized in that: The invention comprises a body (1), wherein the body (1) is an alloy comprising the following components: magnesium, zinc and calcium.

2. The absorbable skull shaping device according to claim 1, characterized in that: The weight ratio of magnesium, zinc and calcium is: 80-95g: 3-8g: 1-5g; The outer side of the body (1) is coated with a polylactic acid coating of 0.1-1 mm.

3. The absorbable skull shaping device according to claim 2, characterized in that: The weight of each component of the alloy per 100g is: 92g magnesium, 5g zinc and 3g calcium. The thickness of the polylactic acid coating is 0.5 mm.

4. The absorbable skull shaping device according to any one of claims 1 to 3, characterized in that: The body (1) comprises an elastic portion (3), a connecting portion (2) and a joining portion (4). The connecting portion (2) is arranged on both sides of the elastic portion (3), and the engaging portion (4) is arranged at the outer end of the connecting portion (2).

5. The absorbable skull shaping device according to claim 4, characterized in that: The engaging portion (4) comprises engaging teeth (41).

6. The absorbable skull shaping device according to claim 5, characterized in that: The engaging teeth (41) include a plurality of U-shaped engaging teeth (42) arranged at intervals on the outer end of the connecting portion (2); The U-shaped engaging teeth (42) face outward.

7. The absorbable skull shaping device according to claim 6, characterized in that: The root (43) of the U-shaped engaging tooth (42) is fixed on the connecting portion (2), and the tip (45) of the U-shaped engaging tooth (42) is hook-shaped.

8. The absorbable skull shaping device according to claim 7, characterized in that: The interval between the two ends of the body is in the range of 10-60 mm, and the length of the connecting part is 30-40 mm; In the extended state: the angle of the connection is 100-130 degrees.

9. The absorbable skull shaping device according to claim 8, characterized in that: The length of the joint (4) is 10-12 mm; The root distance between two adjacent U-shaped engaging teeth (42) is 3-4 mm; The length of the root is 3-4 mm; the length of the tip is 2-3 mm; The yield strength of the body is: 150Mpa; shear modulus: 16.67Gpa; elastic modulus: 45GPa; looseness ratio ν\nuν: 0.35; wire diameter: 1.5mm; torsion angle: 10.6 degrees; maximum elastic force: 8-10N; Torque: 0.28 Nm; Stiffness: k = 160 N / m.

10. The absorbable skull shaping device according to claim 9, characterized in that: The body (1) is installed in the bone suture (51) of the skull (5), and the joint (4) cooperates with the skull (5) on both sides of the bone suture (51).